NDC Package 47426-304-01 Zynrelef

Bupivacaine And Meloxicam Solution Infiltration - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
47426-304-01
Package Description:
1 CARTON in 1 KIT / 1 VIAL, SINGLE-DOSE in 1 CARTON (47426-304-03) / 2.3 mL in 1 VIAL, SINGLE-DOSE (47426-304-05)
Product Code:
Proprietary Name:
Zynrelef
Non-Proprietary Name:
Bupivacaine And Meloxicam
Substance Name:
Bupivacaine; Meloxicam
Usage Information:
ZYNRELEF is indicated in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty.
11-Digit NDC Billing Format:
47426030401
NDC to RxNorm Crosswalk:
  • RxCUI: 2560306 - ZYNRELEF (BUPivacaine 200 MG / meloxicam 6 MG) in 7 ML Extended Release Solution
  • RxCUI: 2560306 - 7 ML bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection [Zynrelef]
  • RxCUI: 2560306 - Zynrelef (bupivacaine 200 MG / meloxicam 6 MG) per 7 ML Extended Release Solution
  • RxCUI: 2560308 - ZYNRELEF (BUPivacaine 400 MG / meloxicam 12 MG) in 14 ML Extended Release Solution
  • RxCUI: 2560308 - 14 ML bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection [Zynrelef]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Heron Therapeutics, Inc.
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Infiltration - Administration that results in substances passing into tissue spaces or into cells.
  • Sample Package:
    No
    FDA Application Number:
    NDA211988
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    07-01-2021
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 47426-304-01?

    The NDC Packaged Code 47426-304-01 is assigned to a package of 1 carton in 1 kit / 1 vial, single-dose in 1 carton (47426-304-03) / 2.3 ml in 1 vial, single-dose (47426-304-05) of Zynrelef, a human prescription drug labeled by Heron Therapeutics, Inc.. The product's dosage form is solution and is administered via infiltration form.

    Is NDC 47426-304 included in the NDC Directory?

    Yes, Zynrelef with product code 47426-304 is active and included in the NDC Directory. The product was first marketed by Heron Therapeutics, Inc. on July 01, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 47426-304-01?

    The 11-digit format is 47426030401. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-247426-304-015-4-247426-0304-01